Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a polymorphic, multisystemic autoimmune disease that causes multiorgan damage in which cellular communication occurs through the involvement of autoantibodies directed against autoantigen production. Mesenchymal stem cells (MSCs), which have strong protective an...

Full description

Bibliographic Details
Main Authors:	Tianbiao Zhou, Hong-Yan Li, Chunling Liao, Wenshan Lin, Shujun Lin
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.1155/2020/6518508

Similar Items

Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis
by: Tianbiao Zhou, et al.
Published: (2020-02-01)

Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants
by: Shujun Lin, et al.
Published: (2020-01-01)

The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
by: Tianbiao Zhou, et al.
Published: (2020-01-01)

Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis
by: Wenshan Lin, et al.
Published: (2021-01-01)

An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus
by: Qian Yang, et al.
Published: (2021-01-01)

Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis
by: Tianbiao Zhou, et al.
Published: (2019-10-01)

Efficacy and Safety of Vaccinations in Systemic Lupus Erythematosus
by: Philip Hei Li, et al.
Published: (2020-07-01)

Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
by: Per Eriksson, et al.
Published: (2019-02-01)

Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus
by: Yantong Zhu, et al.
Published: (2018-05-01)

Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus
by: Aifen Li, et al.
Published: (2021-09-01)

Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells
by: Lihui Wen, et al.
Published: (2019-01-01)

Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis
by: Liying Peng, et al.
Published: (2020-09-01)

Relationship between TGF-β1 + 869 T/C and + 915 G/C gene polymorphism and risk of acute rejection in renal transplantation recipients
by: Hong-Yan Li, et al.
Published: (2019-06-01)

Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience
by: Dandan Wang, et al.
Published: (2013-12-01)

CLINICAL EFFICACY OF EXTRA-CORPOREAL PHOTOCHEMOTHERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. V. Molochkov, et al.
Published: (2016-02-01)

In vitro regulation of IL-6 and TGF-ß by mesenchymal stem cells in systemic lupus erythematosus patients
by: Dewi Masyithah Darlan, et al.
Published: (2020-08-01)

Association of TNF-α with Impaired Migration Capacity of Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
by: Linyu Geng, et al.
Published: (2014-01-01)

Association of hypoxia-inducible factor-1α (HIF1α) 1790G/A gene polymorphism with renal cell carcinoma and prostate cancer susceptibility: a meta-analysis
by: Hong-Yan Li, et al.
Published: (2019-08-01)

Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: A meta-analysis.
by: Ma Yubo, et al.
Published: (2017-01-01)

Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01)

Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus
by: Alberto M. Marmont du Haut Champ
Published: (2012-01-01)

RESULTS OF AN OBSERVATIONAL PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF BELIMUMAB (BENLYSTA®) IN SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL CLINICAL PRACTICE
by: E. A. Aseeva, et al.
Published: (2016-03-01)

Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus
by: G. M. Tarasova, et al.
Published: (2021-06-01)

Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study
by: Tomas Walhelm, et al.
Published: (2021-10-01)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
by: Qiu-Xia Mao, et al.
Published: (2017-04-01)

Lupus erythematosus tumidus: clinical perspectives
by: Patsinakidis N, et al.
Published: (2019-10-01)

Clinical characteristics of cutaneous lupus erythematosus
by: Justyna Szczęch, et al.
Published: (2016-02-01)

Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus
by: Dandan Wang, et al.
Published: (2012-01-01)

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
by: Patrick Muller, et al.
Published: (2020-07-01)

Retraction Note: Purified umbilical cord derived mesenchymal stem cell treatment in a case of systemic lupus erythematosus
by: Christopher D. Phillips, et al.
Published: (2018-09-01)

RETRACTED ARTICLE: Purified umbilical cord derived mesenchymal stem cell treatment in a case of systemic lupus erythematosus
by: Christopher D. Phillips, et al.
Published: (2017-08-01)

Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus
by: Juhi Sharma, et al.
Published: (2017-05-01)

Umbilical Cord-Derived Mesenchymal Stem Cells Suppress Autophagy of T Cells in Patients with Systemic Lupus Erythematosus via Transfer of Mitochondria
by: Jinyun Chen, et al.
Published: (2016-01-01)

Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1
by: Wang Chun, et al.
Published: (2021-09-01)

Safety of Mesenchymal Stem Cells for Clinical Application
by: Youwei Wang, et al.
Published: (2012-01-01)

Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells
by: Chen Dong, et al.
Published: (2019-01-01)

Meta-analysis of associations of vascular endothelial growth factor protein levels and -634G/C polymorphism with systemic lupus erythematosus susceptibility
by: Wenzhuang Tang, et al.
Published: (2019-03-01)

Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
Published: (2020)

EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES
by: Ekaterina I. Alexeeva, et al.
Published: (2016-11-01)

Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis
by: Hanxiao You, et al.
Published: (2020-01-01)